Gyre Therapeutics GYRE
NASDAQ GYRE
$4.23 -0.42 (-9.03%)
At close: Nov 10, 2026 · 4:00 PM EST

Gyre Therapeutics (GYRE) Share-based Compensation (IS) (2011 - 2012)

Updated

Gyre Therapeutics' Share-based Compensation (IS) came in at $1.44 million for Q3 2012, down 33.0% from $2.15 million a year earlier and down 53.7% from the prior quarter.

Analysis

Gyre Therapeutics (GYRE) Share-based Compensation (IS) (2011 - 2012) Analysis & Trends

Over the trailing twelve months to Sep 30, 2012, Gyre Therapeutics reported Share-based Compensation (IS) of $8.9 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Gyre Therapeutics 487.81 Mn 295.13 Mn 30.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 1.44 Mn
Jun 30, 2012 3.11 Mn
Sep 30, 2011 2.15 Mn
Jun 30, 2011 2.20 Mn
API Access

Gyre Therapeutics Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=GYRE&period=max&api_key=YOUR_API_KEY